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The Necessity of Validated Questionnaires: 
Determining Accurate Responses to Proton 
Pump Inhibitor Use
TO THE EDITOR: The paper of Dickman et al
1 showed inter-
esting results that patients refractory to proton pump inhibitors 
(PPI) showed atypical gastroesophageal reflux disease (GERD) 
symptoms, disease duration and severity, Helicobacter pylori sta-
tus, and obesity. They investigated the patients’ compliance to 
medication, the presence of atypical GERD symptoms, and the 
patients’ responsiveness to PPI. However, it is not certain wheth-
er the questionnaires that they have used were well-validated or 
not. Questionnaires like GERD-Q or Mayo Dysphagia Que-
sionnaire-30 days are known to be fully validated after the con-
firmation of reproducibility. Consequently, fully validated ques-
tionnaires would be better in detecting significant differences 
among the success and failure of groups taking PPI once or twice 
per day.
2-4 In addition to the questionnaire, patients were retro-
spectively asked about their medication compliance, and ver-
ification of that compliance was based solely on the patients’ 
words. More objective methods, such as checking the remaining 
number of PPI tablets, might be a more reasonable and precise 
method to determine the compliance rather than relying on the 
patients’ replies to the question. As a result of this bias, the assess-
ment of patients’ response to the medication might be too sub-
jective and it may not reflect the true effect to medication itself. 
Moreover, the design of this study did not involve the con-
comitant use of double blind, placebo medication. Therefore, the 
patients who answered that they were responsive to PPI might 
have been experiencing a significant placebo effect. To overcome 
those limitations, the use of well-validated questionnaires might 
be needed in this study.
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